Asston Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	1.8	1.99	0.06	1.24	1.37	0.32
Cash & Short-Term Investments	1.8	1.99	0.06	1.24	1.37	0.32
Cash Growth	45.67%	3010.94%	-94.83%	-9.58%	321.05%	-92.16%
Accounts Receivable	335.69	245.49	161.52	86.09	64.03	42.55
Receivables	335.69	245.49	161.52	86.09	67.39	42.55
Inventory	6.26	7.17	14.39	15.01	5.03	12.52
Other Current Assets	34.51	15.53	7.39	4.6	-	4.54
Total Current Assets	378.25	270.19	183.36	106.93	73.79	59.94
Property, Plant & Equipment	13.27	9.56	10.91	11.31	9.18	9.24
Long-Term Deferred Tax Assets	0.32	0.23	-	-	-	-
Other Long-Term Assets	0	1.25	8.34	6.73	0	-
Total Assets	494.79	281.23	202.6	136.94	94.91	69.18
Accounts Payable	50.32	58.62	58.1	55.4	45.3	43.45
Accrued Expenses	-	12.1	6.67	4.73	3.33	0.21
Short-Term Debt	-	37.29	45.54	31.31	23.13	-
Current Portion of Long-Term Debt	22.59	12.72	6.39	2.95	0.56	-
Current Income Taxes Payable	-	17.87	3.62	3.48	0.21	-
Other Current Liabilities	16.6	11.29	0.25	-	3.03	0.27
Total Current Liabilities	89.51	149.88	120.58	97.88	75.56	43.93
Long-Term Debt	17.33	22.57	16.27	18.19	9.41	23.88
Pension & Post-Retirement Benefits	1.61	1.61	1.6	0.69	0.49	-
Long-Term Deferred Tax Liabilities	-	-	0.24	0.33	0.17	0.07
Other Long-Term Liabilities	0	-0	-0	-	-	-
Total Liabilities	108.45	174.05	138.68	117.08	85.62	67.89
Common Stock	85.12	62.71	7.84	7	7	0.1
Additional Paid-In Capital	-	-	29.62	-	-	-
Retained Earnings	-	44.46	26.46	12.86	2.3	1.19
Comprehensive Income & Other	301.22	-0	-	-	-0.01	-
Shareholders' Equity	386.34	107.18	63.93	19.86	9.29	1.29
Total Liabilities & Equity	494.79	281.23	202.6	136.94	94.91	69.18
Total Debt	39.92	72.57	68.2	52.45	33.1	23.88
Net Cash (Debt)	-38.12	-70.58	-68.14	-51.21	-31.73	-23.56
Net Cash Per Share	-5.83	-11.25	-12.17	-9.15	-333.35	-294.47
Filing Date Shares Outstanding	6.8	6.27	6.27	0.7	0.1	0.08
Total Common Shares Outstanding	6.8	6.27	6.27	0.7	0.1	0.08
Working Capital	288.74	120.31	62.78	9.05	-1.77	16.01
Book Value Per Share	56.82	17.09	10.19	28.37	97.68	16.08
Tangible Book Value	386.34	107.18	63.93	19.86	9.29	1.29
Tangible Book Value Per Share	56.82	17.09	10.19	28.37	97.68	16.08
Buildings	-	-	9.32	9.32	9.32	9.32
Machinery	-	10.95	2.73	2.63	0.12	0.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.